While APOD is significantly downregulated in CE skin fibroblasts when compared to control females, the increased expression of APOD was found in patients affected by a variety of disorders, including schizophrenia, Alzheimer’s disease, Parkinson’s disease, bipolar disorder, and multiple sclerosis [25,49,52]. Here, APOD is linked to Parkinson disease.